Jack Hoppin is the founder of Ratio Therapeutics. Ratio Therapeutics has raised $90M in total funding. Latest round: Series B.
Dr. Jack Hoppin is the Founder, CEO, and Chairman of Ratio Therapeutics, a pharmaceutical company focused on developing targeted radiotherapeutics for cancer treatment. He leads the company's efforts to address the challenges of delivering safe and effective radiopharmaceuticals for solid cancers.
Full founder directory · Investor directory · Company funding database · Fundraising library